Browse By

Daily Archives: August 5, 2017

No Thumbnail

Teva Pharmaceutical Misses Q2 Profit Estimates

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported second quarter results that missed analysts’ estimates. In the second quarter, profit, excluding some costs, dropped to $1 billion from $1.23 billion a year earlier. That was lower than the $1.12 billion average of analysts’ estimates compiled by Bloomberg.